Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- Made by Novo Nordisk
- Approved specifically for weight loss
- Well-established track record (longer on market)
Zepbound (tirzepatide)
- Dual GIP + GLP-1 receptor agonist
- Made by Eli Lilly
- Generally shows slightly greater average weight loss in clinical trials (~20-22% vs ~15%)
- Newer but strong data
Which to Ask For?
Ask about Zepbound first if maximum weight loss is your goal — the trial data is compelling. However, Wegovy may be better if you have specific cardiovascular risk factors or your insurance covers it preferentially.
Where to Get Either Online
Reputable telehealth platforms:
- Hims & Hers – offers both (or compounded versions)
- WeightWatchers Clinic (Sequence) – prescription + coaching
- Ro Body – straightforward process
- Noom Med – combines behavioral support
- Found – good for ongoing management
Important Notes
- ⚠️ Verify the platform requires a real medical consultation
- Check your insurance — both are expensive (~$1,000+/month without coverage)
- Avoid any site that skips the prescription process entirely
Want specifics on cost or insurance navigation?